PALI
Palisade Bio, Inc.
There isn't enough reported data to score PALI yet.
PALI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Weak | |
| Unavailable |
PALI's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
PALI PE Valuation
PALI has no meaningful PE right now: it lost money over the past year.
PALI Forward outlook
There aren't enough analyst estimates for PALI to show an outlook.
PALI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$13.83 | +$71.28 |
| Q2 2024 | -$18.86 | +$118.90 |
| Q1 2024 | -$23.49 | +$196.32 |
| Q4 2023 | -$27.00 | +$328.85 |
| Q3 2023 | -$85.11 | -116% |
| Q2 2023 | -$137.76 | -115% |
| Q1 2023 | -$219.81 | +$1,874.33 |
| Q4 2022 | -$355.85 | +$2,186.65 |
PALI lost $13.83 per share over the past year, a smaller loss than the year before.
PALI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2020 | $2.5K | 0% |
PALI's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2340% | N/A |
| Q1 2023 | -1012% | N/A |
| Q4 2020 | -175764% | -90461 points |
| Q3 2020 | -93745% | N/A |
| Q2 2020 | -77894% | N/A |
| Q1 2020 | -33064% | N/A |
| Q4 2019 | -85303% | N/A |
PALI's operating margin was −2340% last quarter, up 75555 points from the same quarter a year ago.
PALI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.8M | -$8.2M |
| Q2 2026 | -$7.6M | -$5.8M |
| Q1 2026 | -$3.9M | -$1.6M |
| Q4 2025 | -$3.1M | -$763K |
| Q3 2025 | -$3.6M | -$420K |
| Q1 2025 | -$2.3M | +$847K |
| Q4 2024 | -$2.4M | +$365K |
| Q3 2024 | -$3.1M | -$471K |
PALI has burned cash in almost every quarter: −$26M over the past year, against −$10M the year before.
PALI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +646K shares |
| 1 year | +4320% | +207M shares |
| 3 years | +73597% | +212M shares |
| 5 years | +6879452% | +212M shares |
PALI has 212M diluted shares, up 4320% from a year ago.
PALI Net Leverage
PALI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PALI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 4.9 | Oversold |
PALI's weekly RSI is 33 (neutral) and its Stochastic is 5 (oversold).
PALI PE vs Healthcare Sector
PALI has no meaningful PE right now: it lost money over the past year.
PALI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 14% below |
| 20 week MA | $1.73 | 34% below |
| 50 week MA | $1.82 | 37% below |
| 100 week MA | $1.47 | 22% below |
| 200 week MA | $7.14 | 84% below |
PALI is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
PALI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4,103.9 | $4,025.6 | -1.9% |
| 2021 | $4,025.6 | $1,252.5 | -69% |
| 2022 | $1,252.5 | $28.7 | -98% |
| 2023 | $28.7 | $8.85 | -69% |
| 2024 | $8.85 | $1.67 | -81% |
| 2025 | $1.67 | $2.15 | +29% |
| 2026 YTD | $2.15 | $1.14 | -47% |
PALI has finished lower in five of the last six years. It's down 47% so far in 2026.